Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals
Schwab N., Schneider-Hohendorf T., Pignolet B., Brassat D., Wiendl H.
Letter to the editor (journal) | Peer reviewedDetails about the publication
Journal: Neurology
Volume: 95
Issue: 11
Page range: 505null
Status: Published
Release year: 2020
Language in which the publication is written: English
Link to the full text: https://api.elsevier.com/content/abstract/scopus_id/85091051174
Keywords: PML
Authors from the University of Münster
| Schneider-Hohendorf, Tilman |